REDDING, Calif., Aug. 14, 2024 /PRNewswire/ -- According to a
new market research report titled, 'Biopharmaceutical
Processing Equipment and Consumables Market Size,
Share, Forecast, & Trends Analysis by Product Type (Filtration,
Chromatography, Bioreactors, Cell Culture Media, Shakers,
Services), Application (Vaccine, mAb, R&D) - Forecast to
2031,' published by Meticulous Research®, the
global biopharmaceutical processing equipment and consumables
market was valued at $36.38 billion in 2023. This
market is expected to reach $75.72 billion by 2031
from an estimated $40.22
billion in 2024, at a CAGR of 9.5% during the
forecast period of 2024-2031.
Download Sample Report Now-
https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Biopharmaceutical processing involves the study of the
discovery, development, and processing of complex medicines using
living cells and organisms. Biopharmaceuticals include vaccines,
blood and blood components, gene therapies, recombinant therapeutic
proteins, and somatic cells.
This market's growth is primarily due to the rising government
focus on biologics adoption, key players' focus on increasing
manufacturing capacity for biopharmaceuticals, and the growing
adoption of disposable bioprocessing equipment & consumables.
Further potential for market expansion includes the transition to
bioprocessing 4.0, the growing use of customized medications, and
emerging economies.
Emerging Economies to Provide Growth Opportunities for the
Players Operating in the Market
Market demand for consumables and equipment related to
biopharmaceutical processing has been significantly influenced by
developed economies, like the United
States and Europe. The
participants in this industry are progressively focusing on
emerging economies that are still relatively underdeveloped, as
these markets have comparatively stronger penetration. Growing
demand for biopharmaceutical processing supplies and equipment, an
aging population with infectious and chronic illnesses, rising
costs for pharmaceutical R&D, the growing need for biologics,
and rising disposable income all point to high growth potential in
emerging nations in Asia and
Latin America.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=4200
The biopharmaceutical industry is expanding throughout
China, India, and the member countries of the
Association of Southeast Asian Nations (ASEAN) in the Asia-Pacific region, as well as Brazil and Mexico in Latin
America. This growth is being fuelled by rising public &
private funding for research & development as well as
increasing contract research and manufacturing activities. The
biopharmaceutical industries are being forced to outsource
research, development, and manufacturing in order to save money and
time due to the increasing demand for biopharmaceuticals and the
mounting need to reduce the excessive cost of development. As a
result, CDMOs in developing countries are expanding quickly and
actively engaged in the creation and advancement of
biopharmaceuticals.
This is attributed to growing investments in infrastructure and
capacity development, low labor costs, improving adherence to
global manufacturing standards, and increasing regulatory
oversight.
The key players operating in the global biopharmaceutical
processing equipment and consumables market are 3M Company
(U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad
Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent
Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG
(Germany), Merck KGaA
(Germany), Eppendorf AG
(Germany), and Solaris
Biotechnology Srl (Italy).
The global biopharmaceutical processing equipment and
consumables market is segmented by product type into filtration
systems, chromatography equipment and consumables, bioreactors,
cell culture products, mixers/mixing systems, bioprocessing
containers, sterilizers, centrifuges, incubators, shakers,
biosafety cabinets, and other consumables and accessories.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=4200
By product, in 2024, the filtration systems segment is estimated
to account for the largest share, 22.3%, of the
biopharmaceutical processing equipment and consumables market.
Critical use of filtration in upstream, process development, and
downstream bioprocessing processes and advancing filtration
technologies to meet growing bioprocessing needs are the factors
contributing to the largest share of the market.
By application, the market for biopharmaceutical processing
equipment and consumables is divided by application into commercial
bioproduction and research bioproduction. The commercial
bioproduction segment is projected to experience the highest growth
rate, with a CAGR of 10.1% from 2024 to 2031. This growth is
driven by factors such as rising regulatory approvals for
biologics, biosimilars, and bio-betters; an increase in biologic
therapeutic agents aimed at addressing the COVID-19 pandemic; and
upcoming patent expirations for biologics, all of which are
expected to boost demand for bioprocessing equipment in the
commercial production of biopharmaceuticals.
Chronic disease is treated with monoclonal antibodies, which are
employed in biologics and biosimilars. The need for monoclonal
antibodies rises in tandem with the incidence and severity of
chronic illnesses. Pharmaceutical and biopharmaceutical businesses
are strengthening their market share by producing antibodies
through bioproduction in order to meet the increasing demand.
By end user, the biopharmaceutical processing equipment and
consumables market is segmented into pharmaceutical and
biopharmaceutical companies, academic & research institutes
contract development and manufacturing organizations (CDMOs). The
CDMOs segment is anticipated to grow at the highest CAGR during the
forecast period. This growth is fuelled by the increasing trend of
outsourcing biopharmaceutical manufacturing to bioprocessing hubs
in countries like India,
South Korea, and Singapore. Pharmaceutical and
biopharmaceutical companies are increasingly outsourcing drug
discovery and manufacturing to shorten drug development timelines,
reduce costs, enhance R&D productivity, and improve operational
flexibility, boosting their profit margins.
By geography, in 2024, Europe
is projected to hold the largest share of 33.5% of the
biopharmaceutical processing equipment and consumables market.
Within Europe, Germany is expected to hold the largest market
share. This prominent position is attributed to Germany's significant pharmaceutical export
volumes, substantial government grants and funding for biotech and
biopharmaceutical companies, and the expansion of biopharmaceutical
companies' capacities to produce biologics-based drugs and
therapeutics in response to growing market demand.
Browse In-depth Report Now-
https://www.meticulousresearch.com/product/biopharmaceutical-processing-equipment-and-consumables-market-4200
Scope of the Report:
Global Biopharmaceutical Processing Equipment and Consumables
Market, by Product Type
- Filtration Systems
- Chromatography Equipment and Consumables
- Chromatography Consumables
- Chromatography Equipment
- Bioreactors
- Reusable Bioreactors
- Single-use Bioreactors
- Cell Culture Products
- Cell Culture Media
- Cell Culture Media, by Physical Form
- Dry Powder Media
- Liquid Media
- Cell Culture Media, by Type
- Off-the-Shelf Media
- Custom Media
- Cell Culture Media, by Source
- Chemically Defined Media
- Natural Media
- Reagents and Supplements
- Cell and Cell Lines
- Serum
- Mixing Systems
- Bioprocessing Containers
- Sterilizers
- Centrifuges
- Incubators
- Shakers
- Biosafety Cabinets
- Other Equipment and Consumables
- Services
Note: Other equipment and consumables include membrane
adsorbers, cell disruption reagents, pipettes, syringes, vials,
closures, tubing, connectors, and sensors
Global Biopharmaceutical Processing Equipment and Consumables
Market, by Application
- Commercial Bioproduction
- Vaccine Manufacturing
- mAb Production
- Recombinant Protein Production
- Cell and Gene Therapy Production
- Research Bioproduction
Global Biopharmaceutical Processing Equipment and Consumables
Market, by End User
- Pharmaceutical & Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations
(CDMOs)
- Academia & Research Institutes
Global Biopharmaceutical Processing Equipment and Consumables
Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Switzerland
- Denmark
- Ireland
- Belgium
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Unlock Opportunities: Buy Now-
https://www.meticulousresearch.com/Checkout/87973509
Related Reports:
Pharmaceutical Processing and Packaging Equipment Market
Size, Share, Forecast, & Trends Analysis by Formulation (Oral,
Parenteral) Secondary Packaging (Cartoning, Labelling) End-of-Line
Packaging (Palletizing, Case Packaging)—Global Forecast to 2031
Pharmaceutical Processing Equipment Market by Mode of
Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages
{Filtration Units}], Parenterals [SIP, CIP, Process Systems],
Topicals [Agitators, Homogenizers, Colloid Mills])—Global Forecasts
to 2029
Continuous Bioprocessing Market by Product (Filtration,
Chromatography, Centrifuges, Consumables), Application (Commercial
{Vaccines, Monoclonal Antibodies}, R&D), End User
(Pharmaceuticals, Biotechnology, CROs), and Geography—Forecast to
2028
Single-use Bioreactors Market by Product [Systems, Media
Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank,
Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application
[Commercial (Mab, Vaccine), Research], End User—Global Forecast to
2030
Cell Culture Market by Product [Consumables (Media,
Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge,
Cell Counter)], Application (Bioproduction, Cancer Research, Stem
Cell, Diagnostic), End User (Pharma, academic)—Global Forecast to
2029
About Meticulous Research®
Meticulous Research® was founded in 2010 and
incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a
private limited company under the Companies Act, 1956. Since its
incorporation, the company has become the leading provider of
premium market intelligence in North
America, Europe,
Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/117/biopharmaceutical-processing-equipment-and-consumables-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/biopharmaceutical-processing-equipment-and-consumables-market-to-be-worth-75-72-billion-by-2031--exclusive-report-by-meticulous-research-302222380.html